One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-147822
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, Azienda Ospedaliera Universitaria Senese, University of Duisburg-Essen, Spedali Civili di Brescia, Queen's Hospital, Klinikum Stuttgart, University Medical Center Hamburg-Eppendorf, Universität Hamburg, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Royal Free London NHS Foundation Trust, University College Hospital, University College London, Schwarzwald-Baar Klinikum, The Christie NHS Foundation Trust, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Verona, Nottingham University Hospitals NHS Trust, Institute of Oncology Research, University Medical Center Freiburg, Azienda Sanitaria Unità Locale di Reggio Emilia, Aarhus University Hospital
Treatment of Patients with Relapsed or Refractory Primary CNS Lymphoma (rrPCNSL) Enrolled in the Randomized Trials of the International Extranodal Lymphoma Study Group (IELSG)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
